GPT and metabolic dysfunction-associated steatotic liver disease: NAFLD mice treated with both AT and RSV exhibited a significant decrease (39.72% and 40.04%, respectively) in the serum activities of ALT and AST compared with untreated NAFLD mice (p = 0.001 and 0.006, respectively).